Pulse Biosciences Completes Enrollment in nPulse Preclinical Study
Pulse Biosciences announced the enrollment of 100 patients across three U.S. sites in the PRECISE-BTN clinical study evaluating its nPulse Percutaneous Electrode System, with first patient visitation marking milestone progress in the development of novel bioelectric medicine for thyroid nodules.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day